Question: Do thiopurine methyl-transferase activity and azathioprine metabolite concentrations predict clinical outcome in thiopurine-treated inflammatory bowel disease patients?
Answer: Our results do not support determination of TPMT activity or 6TGN concentrations to predict treatment outcome, and no useful serum metabolites threshold value to adjust the drug's dose was identified.